ASX:ANR

Anatara Lifesciences Competitors

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume3,950 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Anatara Lifesciences (ASX:ANR) Vs. CHV, DDXS, PREV, TNGN, COM, and MYM

Should you be buying ANR stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Anatara Lifesciences, including (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), and 17031 (MYM).

Anatara Lifesciences vs. (CHV) Stock

(CHV) (CNSX:CHV) and Anatara Lifesciences (ASX:ANR) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

Earnings and Valuation

This table compares (CHV) and Anatara Lifesciences' gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(CHV)	N/A	N/A	N/A	N/A	N/A
Anatara Lifesciences	$268,259.00	0.00	$-3,240,695.58	A($0.05)	N/A

(CHV) has higher earnings, but lower revenue than Anatara Lifesciences.

Analyst Recommendations

This is a summary of current ratings and recommmendations for (CHV) and Anatara Lifesciences, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(CHV)	0	0	0	0	N/A
Anatara Lifesciences	0	0	0	0	N/A

Profitability

This table compares (CHV) and Anatara Lifesciences' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(CHV)	N/A	N/A	N/A
Anatara Lifesciences	N/A	N/A	N/A

Summary

Anatara Lifesciences beats (CHV) on 1 of the 1 factors compared between the two stocks.

Anatara Lifesciences vs. (DDXS) Stock

Anatara Lifesciences (ASX:ANR) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations.

Earnings and Valuation

This table compares Anatara Lifesciences and (DDXS)'s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anatara Lifesciences	$268,259.00	0.00	$-3,240,695.58	A($0.05)	N/A
(DDXS)	N/A	N/A	N/A	N/A	N/A

(DDXS) has lower revenue, but higher earnings than Anatara Lifesciences.

Analyst Recommendations

This is a summary of current ratings for Anatara Lifesciences and (DDXS), as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anatara Lifesciences	0	0	0	0	N/A
(DDXS)	0	0	0	0	N/A

Profitability

This table compares Anatara Lifesciences and (DDXS)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Anatara Lifesciences	N/A	N/A	N/A
(DDXS)	N/A	N/A	N/A

Summary

Anatara Lifesciences beats (DDXS) on 1 of the 1 factors compared between the two stocks.

Anatara Lifesciences vs. (PREV) Stock

(PREV) (CNSX:PREV) and Anatara Lifesciences (ASX:ANR) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for (PREV) and Anatara Lifesciences, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(PREV)	0	0	0	0	N/A
Anatara Lifesciences	0	0	0	0	N/A

Profitability

This table compares (PREV) and Anatara Lifesciences' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(PREV)	N/A	N/A	N/A
Anatara Lifesciences	N/A	N/A	N/A

Earnings & Valuation

This table compares (PREV) and Anatara Lifesciences' top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(PREV)	N/A	N/A	N/A	N/A	N/A
Anatara Lifesciences	$268,259.00	0.00	$-3,240,695.58	A($0.05)	N/A

(PREV) has higher earnings, but lower revenue than Anatara Lifesciences.

Summary

Anatara Lifesciences beats (PREV) on 1 of the 1 factors compared between the two stocks.

Anatara Lifesciences vs. (TNGN) Stock

Anatara Lifesciences (ASX:ANR) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, risk, valuation, dividends and profitability.

Profitability

This table compares Anatara Lifesciences and (TNGN)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Anatara Lifesciences	N/A	N/A	N/A
(TNGN)	N/A	N/A	N/A

Earnings & Valuation

This table compares Anatara Lifesciences and (TNGN)'s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anatara Lifesciences	$268,259.00	0.00	$-3,240,695.58	A($0.05)	N/A
(TNGN)	N/A	N/A	N/A	N/A	N/A

(TNGN) has lower revenue, but higher earnings than Anatara Lifesciences.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Anatara Lifesciences and (TNGN), as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anatara Lifesciences	0	0	0	0	N/A
(TNGN)	0	0	0	0	N/A

Summary

Anatara Lifesciences beats (TNGN) on 1 of the 1 factors compared between the two stocks.

Anatara Lifesciences vs. 138267 (COM.TO) Stock

Anatara Lifesciences (ASX:ANR) and 138267 (COM.TO) (TSE:COM) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, institutional ownership, profitability and dividends.

Profitability

This table compares Anatara Lifesciences and 138267 (COM.TO)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Anatara Lifesciences	N/A	N/A	N/A
138267 (COM.TO)	N/A	N/A	N/A

Earnings and Valuation

This table compares Anatara Lifesciences and 138267 (COM.TO)'s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anatara Lifesciences	$268,259.00	0.00	C$-3,240,695.58	A($0.05)	N/A
138267 (COM.TO)	N/A	N/A	N/A	N/A	N/A

138267 (COM.TO) has lower revenue, but higher earnings than Anatara Lifesciences.

Analyst Ratings

This is a breakdown of current recommendations for Anatara Lifesciences and 138267 (COM.TO), as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anatara Lifesciences	0	0	0	0	N/A
138267 (COM.TO)	0	0	0	0	N/A

Summary

Anatara Lifesciences beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.

Anatara Lifesciences vs. 17031 Stock

Anatara Lifesciences (ASX:ANR) and 17031 (CNSX:MYM) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

Profitability

This table compares Anatara Lifesciences and 17031's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Anatara Lifesciences	N/A	N/A	N/A
17031	N/A	N/A	N/A

Valuation and Earnings

This table compares Anatara Lifesciences and 17031's gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anatara Lifesciences	$268,259.00	0.00	C$-3,240,695.58	A($0.05)	N/A
17031	N/A	N/A	N/A	N/A	N/A

17031 has lower revenue, but higher earnings than Anatara Lifesciences.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Anatara Lifesciences and 17031, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anatara Lifesciences	0	0	0	0	N/A
17031	0	0	0	0	N/A

Summary

Anatara Lifesciences beats 17031 on 1 of the 1 factors compared between the two stocks.